Scholarlink

Background <p>Sjögren’s syndrome is an autoimmune, chronic inflammatory disease characterized by its impact on salivary and lacrimal glands, along with potential involvement of internal organs. Sicca symptoms, such as dry eyes and mouth, are typical features.</p> Case presentation <p>We present the case of a 30-year-old Iraqi woman who presented with meningoencephalitis and acute motor axonal neuropathy, which were unusual as initial manifestations of Sjögren’s syndrome. Initial investigations included a complete blood count, erythrocyte sedimentation rate, C-reactive protein, renal and liver function tests, and cerebrospinal fluid analysis. Brain magnetic resonance imaging showed hyperintense lesions in the brainstem and periventricular regions, and magnetic resonance venography was performed to rule out venous thrombosis. An aquaporin 4 antibody screening test was sent for suspected neuromyelitis optica and returned positive. However, subsequent magnetic resonance imaging scans of the spinal cord and optic nerve found no abnormalities. Serological tests confirmed the presence of antinuclear antibodies, rheumatoid factor, and antibodies against SS-A and SS-B, consistent with Sjögren’s syndrome. The patient was treated with methylprednisolone and intravenous immunoglobulin. Given the suspected diagnosis of Bickerstaff encephalitis, intravenous immunoglobulin was included in the regimen, although it was later ruled out. After 4&#xa0;weeks of treatment, the patient showed significant improvement, regaining consciousness and partial motor function. Several months after symptom onset, the patient achieved independent mobility despite experiencing mild weakness in the right lower limb, and plans were made to initiate either cyclophosphamide or rituximab therapy.</p> Conclusions <p>This case underscores the diverse clinical presentations of Sjögren’s syndrome, highlighting the importance of considering autoimmune etiologies in patients presenting with neurological manifestations such as meningoencephalitis and acute motor axonal neuropathy. Early recognition and management of such atypical presentations are crucial for improving patient outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Meningoencephalitis as a presentation of primary Sjögren’s syndrome: a case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月13日

查看全文
  • Ali Kadim Karim,
  • Faiq I. Gorial,
  • Israa Ali Badi,
  • Farah J. Mahdi,
  • Nabaa Ihsan Awadh,
  • Ahmed Moaffak Hassan,
  • Mohammad Khazaal Juma’a

摘要

Background

Sjögren’s syndrome is an autoimmune, chronic inflammatory disease characterized by its impact on salivary and lacrimal glands, along with potential involvement of internal organs. Sicca symptoms, such as dry eyes and mouth, are typical features.

Case presentation

We present the case of a 30-year-old Iraqi woman who presented with meningoencephalitis and acute motor axonal neuropathy, which were unusual as initial manifestations of Sjögren’s syndrome. Initial investigations included a complete blood count, erythrocyte sedimentation rate, C-reactive protein, renal and liver function tests, and cerebrospinal fluid analysis. Brain magnetic resonance imaging showed hyperintense lesions in the brainstem and periventricular regions, and magnetic resonance venography was performed to rule out venous thrombosis. An aquaporin 4 antibody screening test was sent for suspected neuromyelitis optica and returned positive. However, subsequent magnetic resonance imaging scans of the spinal cord and optic nerve found no abnormalities. Serological tests confirmed the presence of antinuclear antibodies, rheumatoid factor, and antibodies against SS-A and SS-B, consistent with Sjögren’s syndrome. The patient was treated with methylprednisolone and intravenous immunoglobulin. Given the suspected diagnosis of Bickerstaff encephalitis, intravenous immunoglobulin was included in the regimen, although it was later ruled out. After 4 weeks of treatment, the patient showed significant improvement, regaining consciousness and partial motor function. Several months after symptom onset, the patient achieved independent mobility despite experiencing mild weakness in the right lower limb, and plans were made to initiate either cyclophosphamide or rituximab therapy.

Conclusions

This case underscores the diverse clinical presentations of Sjögren’s syndrome, highlighting the importance of considering autoimmune etiologies in patients presenting with neurological manifestations such as meningoencephalitis and acute motor axonal neuropathy. Early recognition and management of such atypical presentations are crucial for improving patient outcomes.